IMARC Group's report titled "Anti-infectives Market Report by Type (Antibacterial, Antifungal, Antiviral), Route of Administration (Topical, Oral, Intravenous (IV), and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Speciality Pharmacies, Online Stores, and Others), and Region 2024-2032". offers a comprehensive analysis of the industry, which comprises insights on the global anti-infectives market report. The global market size reached US$ 134.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 177.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.05% during 2024-2032.

Grab a sample PDF of this report: https://www.imarcgroup.com/anti-infectives-market/requestsample

Factors Affecting the Growth of the Anti-Infectives Industry:

• Increasing Prevalence of Infectious Diseases:

Climate change alters ecosystems and weather patterns, influencing the distribution and prevalence of infectious diseases. Changes in temperature, precipitation, and humidity can affect the range and activity of disease vectors, such as mosquitoes carrying malaria or dengue fever. Environmental degradation, deforestation, and urban expansion can also bring humans into closer contact with wildlife reservoirs of infectious agents, increasing the risk of zoonotic diseases. These environmental changes contribute to the emergence and re-emergence of infectious diseases, driving the demand for anti-infective medications.

• Technological Advancements:

Innovations enable the identification of specific molecular targets essential for the survival or replication of pathogens. This knowledge allows for the design of targeted therapies that selectively inhibit microbial targets while minimizing off-target effects on host cells. Targeted therapies offer the potential for enhanced efficacy and reduced toxicity compared to broad-spectrum antibiotics, contributing to the advancement of precision medicine in infectious disease treatment.

• Increasing Healthcare Expenditure:

Healthcare expenditure supports antimicrobial stewardship programs aimed at optimizing the use of antibiotics and other anti-infective medications. These programs promote judicious antibiotic prescribing practices, surveillance of antimicrobial resistance, and implementation of infection prevention and control measures. Investments in antimicrobial stewardship initiatives help in combating antibiotic resistance, prolong the effectiveness of existing antimicrobial agents, and reduce the burden of infectious diseases.

Leading Companies Operating in the Global Anti-Infectives Industry:

• Abbott Laboratories
• Cipla Health Ltd. (Cipla Limited)
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Glenmark Pharmaceuticals Limited
• Johnson & Johnson
• Lupin Limited
• Sandoz AG (Novartis AG)
• Sun Pharmaceutical Industries Limited

Anti-Infectives Market Report Segmentation:

By Type:

• Antibacterial
• Antifungal
• Antiviral

Antiviral represents the largest segment on account of the increasing prevalence of viral infections, such as influenza, human immunodeficiency virus (HIV), and hepatitis, driving the demand for antiviral medications.

By Route of Administration:

• Topical
• Oral
• Intravenous (IV) 
• Others

Oral accounts for the majority of the market share due to its convenience, patient preference, and ease of administration, especially for chronic infectious diseases requiring long-term treatment.

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Speciality Pharmacies
• Online Stores
• Others

Hospital pharmacies exhibit a clear dominance in the market as hospitals are major healthcare providers for acute and severe infectious diseases, necessitating a high volume of anti-infective medications.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys the leading position in the anti-infectives market owing to the advanced healthcare infrastructure, high healthcare spending, strong R&D capabilities, and a large patient population requiring anti-infective treatments.

Global Anti-Infectives Market Trends:

Advancements in biotechnology, genomics, and drug delivery systems are facilitating the development of more targeted and efficient anti-infective treatments, improving patient outcomes. Emphasis on preventive measures, including vaccination programs, is increasing to reduce the burden of infectious diseases and lower the demand for anti-infective medications.

The growing awareness among the masses about the importance of global health security is driving collaborations between governments, healthcare organizations, and pharmaceutical companies to strengthen preparedness for infectious disease outbreaks and pandemics. There is a trend of outpatient management of infectious diseases, catalyzing the demand for oral and outpatient-administered anti-infective medications, such as oral antibiotics and antivirals.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163